Sense of smell may hold clues to Lewy body pathology: new evidence emerges

The FDA has ac­cept­ed the BLA from blue­bird bio for its gene ther­a­py lovotibeglo­gene au­totem­cel, or lo­vo-cel, de­signed to treat pa­tients with sick­le cell dis­ease

WASH­ING­TON — Two top lead­ers from the FDA said changes to the agency’s ad­vi­so­ry com­mit­tee process won’t elim­i­nate the up-or-down votes whose ne­ces­si­ty Com­mis­sion­er Rob